Novo Nordisk A Fs reported DKK14.4B in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Ani Pharmaceuticals ANIP:US USD -8600000 6.32M
Aurora Cannabis Inc ACB:CN CAD -51604000 567.18M
Bristol Myers Squibb BMY:US USD 1.61B 185M
Canopy Growth Corp WEED:CN CAD -221806000 1.86B
Corcept Therapeutics CORT:US USD 34.61M 7.2M
Drreddys Laboratories RDY:US INR 11.13B 748M
Eli Lilly And LLY:US USD 1.45B 499.2M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Horizon Pharma HZNP:US USD 135.84M 74.86M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Lannett LCI:US USD -28019000 65.28M
Merk MRK:US USD 3.25B 696M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Novartis NOVN:VX USD 1.57B 121M
Novo Nordisk A Fs NVO:US DKK 14.4B 1.09B
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Perrigo Ordinary Shares PRGO:US USD -49400000 15.7M
Prestige Brands PBH:US USD 51.02M 4.25M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M
Valeant Pharmaceuticals VRX:CN USD 399M 544M
Zoetis ZTS:US USD 529M 0